LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration

Peer Review reports

Original Submission
31 Aug 2023	Submitted	Original manuscript
6 Oct 2023	Reviewed	Reviewer Report
27 Oct 2023	Reviewed	Reviewer Report - Hamza S. Gorsi
5 Dec 2023	Reviewed	Reviewer Report
19 Dec 2023	Author responded	Author comments - Olaf Witt
Resubmission - Version 2
19 Dec 2023	Submitted	Manuscript version 2
27 Dec 2023	Reviewed	Reviewer Report
27 Dec 2023	Reviewed	Reviewer Report - Hamza S. Gorsi
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
2 Jan 2024	Editorially accepted
30 Jan 2024	Article published	10.1186/s12885-024-11820-x

Back to article page